- Current report filing (8-K)
12 Novembro 2009 - 1:43PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
|
Date of Report (Date of Earliest Event Reported):
|
|
November 11, 2009
|
Altus Pharmaceuticals Inc.
__________________________________________
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
|
0-51711
|
04-3573277
|
_____________________
(State or other jurisdiction
|
_____________
(Commission
|
______________
(I.R.S. Employer
|
of incorporation)
|
File Number)
|
Identification No.)
|
|
|
|
PO Box 403, Burlington, Massachusetts
|
|
01803
|
_________________________________
(Address of principal executive offices)
|
|
___________
(Zip Code)
|
|
|
|
Registrants telephone number, including area code:
|
|
781-373-6000
|
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.03 Bankruptcy or Receivership.
On November 11, 2009, Altus Pharmaceuticals Inc. (the "Company") filed a voluntary petition for relief (the "Bankruptcy Filing") under Chapter 7 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Massachusetts (the "Bankruptcy Court"). In connection with the Bankruptcy Filing, the Company has ceased all business activity and operations.
The Company’s Chapter 7 case will be administered by the Bankruptcy Court as Case No. 09-20886.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
|
|
|
|
|
Altus Pharmaceuticals Inc.
|
|
|
|
|
|
November 12, 2009
|
|
By:
|
|
Thomas J. Phair, Jr.
|
|
|
|
|
|
|
|
|
|
Name: Thomas J. Phair, Jr.
|
|
|
|
|
Title: Vice President, Finance and Treasurer
|
Altitude Acquisition (NASDAQ:ALTU)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Altitude Acquisition (NASDAQ:ALTU)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024